Art

J-GLOBAL ID：202002211210158905   Reference number：20A2755214

Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR)

早期乳癌に対するネオアジュバント化学療法後の造影MRI(CE-MRI)における放射線学的完全応答(CRR)は,無再発生存を予測するが,病理学的完全応答(pCR)は予測しない【JST・京大機械翻訳】

Author (20)： Gampenrieder Simon Peter (Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Au...) ,  Gampenrieder Simon Peter (Cancer Cluster Salzburg, Salzburg, Austria) ,  Peer Andreas (Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Au...) ,  Weismann Christian (Department of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria) ,  Meissnitzer Matthias (Department of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria) ,  Rinnerthaler Gabriel (Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Au...) ,  Rinnerthaler Gabriel (Cancer Cluster Salzburg, Salzburg, Austria) ,  Webhofer Johanna (Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Au...) ,  Westphal Theresa (Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Au...) ,  Riedmann Marina (Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, Innsbruck, Austria) ,  Meissnitzer Thomas (Department of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria) ,  Egger Heike (Department of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria) ,  Federspiel Frederike Klaassen (Department of Special Gynecology and Breast Center, Paracelsus Medical University Salzburg, Salzburg, Austria) ,  Reitsamer Roland (Department of Special Gynecology and Breast Center, Paracelsus Medical University Salzburg, Salzburg, Austria) ,  Hauser-Kronberger Cornelia (Department of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria) ,  Stering Katharina (Department of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria) ,  Hergan Klaus (Department of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria) ,  Mlineritsch Brigitte (Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Au...) ,  Greil Richard (Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Au...) ,  Greil Richard (Cancer Cluster Salzburg, Salzburg, Austria)
Material： Breast Cancer Research (Web)
Volume： 21  Issue： 1  Page： 1-11  Publication year： 2019 
JST Material Number： U7313A  ISSN： 1465-542X  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Patients with early breast can...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2755214&from=J-GLOBAL&jstjournalNo=U7313A") }}

Thesaurus term： multivariate analysis ,  tumor ,  breast ,  hormone receptor ,  *radiology ,  mastectomy ,  prognosis ,  *breast tumor ,  *pathological state
Semi thesaurus term： *無再発生存率 ,  Kaplan-Meier法 ,  完全寛解 ,  *ネオアジュバント化学療法 ,  長期予後 ,  全生存率 , 【Automatic Indexing@JST】

Author keywords (5)： Breast cancer ,  MRI ,  Neoadjuvant chemotherapy ,  Prediction of complete pathologic response ,  Survival

JST classification (2)： Treatment for tumors in general  (GE03031L) ,  Tumors(=neoplasms)of digestive system  (GH04000D)

Reference (35)：

• PLoS One; Both carboplatin and bevacizumab improve pathological complete remission rate in neoadjuvant treatment of triple negative breast cancer: a meta-analysis; XS Chen, Y Yuan, DH Garfield, JY Wu, O Huang, KW Shen; 9; 9; 2014; 10.1371/journal.pone.0108405; citation_id=CR1
• Ann Oncol; Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA); A Schneeweiss, S Chia, T Hickish, V Harvey, A Eniu, R Hegg, C Tausch, JH Seo, YF Tsai, J Ratnayake; 24; 9; 2013; 2278-2284; 10.1093/annonc/mdt182; citation_id=CR2
• Lancet; Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis; P Cortazar, L Zhang, M Untch, K Mehta, JP Costantino, N Wolmark, H Bonnefoi, D Cameron, L Gianni, P Valagussa; 384; 9938; 2014; 164-172; 10.1016/S0140-6736(13)62422-8; citation_id=CR3
• Lancet Oncol; Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials; ; 19; 1; 2018; 27-39; 10.1016/S1470-2045(17)30777-5; citation_id=CR4
• Ann Oncol; De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017; G Curigliano, HJ Burstein, PW E, M Gnant, P Dubsky, S Loibl, M Colleoni, MM Regan, M Piccart-Gebhart, HJ Senn; 28; 8; 2017; 1700-1712; 10.1093/annonc/mdx308; citation_id=CR5

Terms in the title (11)： 早期乳癌 ,  ネオアジュバント化学療法 ,  造影MRI ,  Ce ,  MRI ,  放射線学 ,  応答 ,  無再発生存 ,  予測 ,  病理学 ,  PCR